Novartis delivered strong growth in priority brands and launches in Q1; FY 2026 guidance reaffirmed
Summary
Ad hoc announcement pursuant to Art. 53 LR
Description
Ad hoc announcement pursuant to Art. 53 LR
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source